Performance of Deep Learning Architectures and Transfer Learning for Detecting Glaucomatous Optic Neuropathy in Fundus Photographs. by Christopher, Mark et al.
UC San Diego
UC San Diego Previously Published Works
Title
Performance of Deep Learning Architectures and Transfer Learning for Detecting 
Glaucomatous Optic Neuropathy in Fundus Photographs.
Permalink
https://escholarship.org/uc/item/5s90h992
Journal
Scientific reports, 8(1)
ISSN
2045-2322
Authors
Christopher, Mark
Belghith, Akram
Bowd, Christopher
et al.
Publication Date
2018-11-12
DOI
10.1038/s41598-018-35044-9
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
1SCIENtIfIC REPORTs |         (2018) 8:16685  | DOI:10.1038/s41598-018-35044-9
www.nature.com/scientificreports
Performance of Deep Learning 
Architectures and Transfer Learning 
for Detecting Glaucomatous Optic 
Neuropathy in Fundus Photographs
Mark Christopher1, Akram Belghith1, Christopher Bowd1, James A. Proudfoot1, 
Michael H. Goldbaum1, Robert N. Weinreb1, Christopher A. Girkin2, Jeffrey M. Liebmann3 & 
Linda M. Zangwill1
The ability of deep learning architectures to identify glaucomatous optic neuropathy (GON) in fundus 
photographs was evaluated. A large database of fundus photographs (n = 14,822) from a racially 
and ethnically diverse group of individuals (over 33% of African descent) was evaluated by expert 
reviewers and classified as GON or healthy. Several deep learning architectures and the impact of 
transfer learning were evaluated. The best performing model achieved an overall area under receiver 
operating characteristic (AUC) of 0.91 in distinguishing GON eyes from healthy eyes. It also achieved 
an AUC of 0.97 for identifying GON eyes with moderate-to-severe functional loss and 0.89 for GON 
eyes with mild functional loss. A sensitivity of 88% at a set 95% specificity was achieved in detecting 
moderate-to-severe GON. In all cases, transfer improved performance and reduced training time. Model 
visualizations indicate that these deep learning models relied on, in part, anatomical features in the 
inferior and superior regions of the optic disc, areas commonly used by clinicians to diagnose GON. 
The results suggest that deep learning-based assessment of fundus images could be useful in clinical 
decision support systems and in the automation of large-scale glaucoma detection and screening 
programs.
Glaucoma is characterized by progressive structural and functional damage to the optic nerve head that can even-
tually lead to functional impairment, disability, and blindness. It is one of the most common causes of irreversible 
blindness worldwide and is expected to affect roughly 80 million people by 20201–3. Current estimates suggest 
that roughly 50% of people suffering from glaucoma in the developed world are currently undiagnosed and aging 
populations suggests that the impact of glaucoma will continue to rise4,5. Effective screening programs to detect 
glaucoma are needed to address this growing public health problem6,7. Despite extensive research on glaucoma 
screening, the U.S. Preventive Services Task Force does not recommend population screening for glaucoma at 
least in part due the relatively low sensitivity and specificity of glaucoma screening tests given the low prevalence 
of the disease and insufficient evidence that the benefits of screening outweigh the costs and potential harm8.
Traditionally, clinicians have examined the ONH with ophthalmoscopy and fundus photography to diagnose 
and monitor glaucoma. Subjective qualitative ONH evaluation requires significant clinical training and agree-
ment is limited even among subspecialty-trained clinicians9–11. Automated methods that use techniques from 
artificial intelligence to objectively interpret images of the ONH and surrounding fundus can help address this 
issue. These automated methods may also be used as part of decision support systems in clinical management of 
glaucoma through incorporation into fundus cameras, electronic medical record systems, or picture archiving 
and communication systems (PACS). If these automated systems can sufficiently improve sensitivity and specific-
ity beyond previously studied glaucoma-associated measurements, they may pave the way for large-scale screen-
ing programs. The Food and Drug Administration (FDA) has recently approved the use of an automated system 
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to review fundus images for diabetic retinopathy12. Similar programs for glaucoma may help improve detection 
rates and identify patients in need of referral to glaucoma specialists.
Over the past several years, deep learning techniques have advanced the state-of-the-art in image classifi-
cation, segmentation, and object detection in medical and ophthalmic images13–15. In particular, deep convo-
lutional neural networks (CNN) have found use in ophthalmology for tasks that include identifying diabetic 
retinopathy in fundus images, interpreting and segmenting optical coherence tomography (OCT) images, and 
detecting drusen, neovascularization, and macular edema by OCT16–19. As opposed to traditional machine learn-
ing approaches that rely on features explicitly defined by experts using their domain knowledge20–23, CNNs are a 
type network that can learn features to maximize the network’s ability to distinguish between healthy and disease 
images. There are many different CNN architectures that have been designed to perform image classification 
and segmentation tasks24. Each of these architectures differ in specific aspects including the number and size of 
features, the connections between these features, and the overall network depth. Because different architectures 
are best suited for different problems and it is difficult to know a priori what architecture is the right choice for a 
given task, empirical testing is often the best way to make this determination25. A problem common to all deep 
learning networks, however, is that they require a much larger amount of data and computation time compared 
to more traditional machine learning techniques. In order to reduce these requirements, transfer learning has 
become an important technique to apply features learned to perform one task to be applied to other tasks26. 
While there are very large (millions of images) datasets available for training general image classifiers, this scale 
of data is unavailable in most medical image classification tasks. By using transfer learning, networks trained on 
general image datasets can be used as a starting point for an ophthalmic task (e.g. classifying fundus images of 
the ONH)26. Transfer learning has previously been employed to train models to detect glaucoma and a variety of 
other diseases from OCT images18,27.
The aim of this work is to develop and evaluate deep learning approaches to identify glaucomatous damage in 
ONH fundus images. Using a large database of ONH-centered fundus images, we evaluated several different CNN 
architectures based on glaucoma diagnostic accuracy. Additionally, we quantitatively evaluated the effect of using 
transfer learning in training these networks.
Methods
Data Collection. Study participants were selected from two prospective longitudinal studies designed to eval-
uate optic nerve structure and visual function in glaucoma: The African Descent and Glaucoma Evaluation Study 
(ADAGES clinicaltrials.gov identifier: NCT00221923) and the University of California, San Diego (UCSD) based 
Diagnostic Innovations in Glaucoma Study (DIGS, clinicaltrials.gov identifier: NCT00221897)28. The ADAGES 
is a multicenter collaboration of the UCSD Hamilton Glaucoma Center, Columbia University Medical Center 
Edward S. Harkness Eye Institute (New York, NY), and the University of Alabama at Birmingham Department 
of Ophthalmology (Birmingham, AL). These are ongoing, longitudinal studies that included periodic collection 
of stereo fundus images. Recruitment and methodology was approved by each institution’s Institutional Review 
Board which adhered to the Declaration of Helsinki and the Health Insurance Portability and Accountability Act. 
Informed consent was obtained from all participants at recruitment. Table 1 summarizes this dataset.
All fundus images included in this work were captured on film as simultaneous stereoscopic ONH photo-
graphs using the Nidek Stereo Camera Model 3-DX (Nidek Inc, Palo Alto, California). Film stereophotographs 
were reviewed by two independent, masked graders for the presence of glaucomatous optic neuropathy (GON) 
using a stereoscopic viewer. If these graders disagreed, a third experienced grader adjudicated. For analysis, pho-
tographs were digitized by scanning 35 mm film slides and storing them as high resolution (~2200 × ~1500 pix-
els) TIFF images. Stereo image pairs were split into individual images of the ONH for analysis. The total dataset 
consisted of 7,411 stereo pairs split into 14,822 individual ONH images collected from 4,363 eyes of 2,329 indi-
viduals. In this analysis, the data was considered cross-sectionally with a binary class (healthy vs. GON) assigned 
at the image level.
Standard automated perimetry visual field (VF) testing using a Humphrey Field Analyzer II (Carl Zeiss 
Meditec, Dubin, CA) with a standard 24-2 testing pattern and the Swedish Interactive Thresholding Algorithm 
was performed on a semi-annual basis. VF tests with more than 33% fixation losses, 33% false negative errors, or 
15% false positive errors were excluded. For each ONH image, the mean deviation (MD) from VF testing closest 
Parameter Healthy GON
Number of participants 1561 768
Number of eyes 2920 1443
Number of images 9189 5633
Visual Field Mean Deviation (dB) −0.76 ± 2.1 −4.1 ± 6.0
Age (years) 53.3 ± 14.4 64.0 ± 12.9
Sex (% female) 63.0 57.0
Race (%)
   White/European descent 64.2 50.8
   Black/African descent 28.0 45.5
   Asian descent 5.3 2.1
   Other/Unreported 2.5 1.6
Table 1. Clinical and demographic characteristics of the optic nerve head (ONH) photograph dataset.
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in time to image acquisition (up to a maximum of one year) was computed and used to estimate VF function at 
the time of imaging. Visual fields were processed and evaluated for quality according to standard protocols by the 
UCSD Visual Field Assessment Center29.
Preprocessing and Data Augmentation. Prior to training the deep learning models, a region centered 
on the ONH was automatically extracted from each fundus image. For our analysis, a separate deep learning 
model was built on a subset of the training data to estimate the location of the disc center. To provide ground 
truth for this model, a single human reviewer marked the ONH center in each of the examples. The resulting 
model was applied to the entire dataset to estimate the ONH center in each image. A square region surrounding 
the estimated center was the extracted from each image for use in the analysis. Each cropped image was manually 
reviewed to ensure that each was correctly centered on the ONH.
A data augmentation procedure was also applied to increase the amount and type of variation within the 
training data. Data augmentation is commonly used in image classification tasks and can result in better per-
forming, more generalizable models that are invariant to certain types of image transformations and variations 
in image quality30. First, horizontally mirrored versions of all images were added to the dataset to mimic the 
inclusion of both OD and OS orientations of each image. Next, a random cropping procedure was applied to all 
images (original and flipped). Specifically, the center of the ONH region cropped from each image was randomly 
perturbed by a small amount to help make the trained models invariant to translational changes and reflect 
clinical care in which ONH photographs are not always well-centered. This random cropping was repeated five 
times for each image. The total augmented dataset contained 148,220 images resulting from (14,822 images) × (2 
orientations) × (5 random crops). Each augmented image was assigned the same label (healthy or GON) as the 
original input image from which it was derived. Figure 1 shows an example input image and the corresponding 
augmentations. After augmentation, all ONH images were down-sampled to a common size of 224 × 224 pixels.
Deep Learning Models. Three different deep learning architectures were evaluated: VGG1631, Inception 
v332, and ResNet5033. These architectures were chosen because they have been widely adopted for both general 
and medical image classification tasks and their performances are commonly used as a comparison for other 
architectures34. Broadly, these architectures are all similar in that they consist of convolutional and pooling layers 
arranged in sequential units and a final, fully connected layer that produces an image-level classification. Each 
architecture differs in the specific arrangement and number of these layers (Fig. 2). Additionally, versions of these 
models that have been trained on a large, general dataset are available so that a transfer learning approach can be 
adopted.
For each architecture under consideration, two different versions were evaluated: native and transfer learn-
ing. In the native version, model weights were randomly initialized35 and training was performed using only the 
fundus ONH data described here. In the transfer learning version, model weights were initialized based on pre-
training on a general image dataset, except for the final, fully connected layers which were randomly initialized. 
Additional training was performed using fundus images to fine-tune these networks for distinguishing healthy vs. 
GON images. In all transfer learning cases, models were initially trained using the ImageNet database36. ImageNet 
is an image dataset containing thousands of different objects and scenes used to train and evaluate image classi-
fication models.
Model Training and Selection. The image dataset was divided randomly divided into multiple folds so 
that 10-fold cross validation could be performed to estimate model performance. Within each fold, the data-
set was partitioned into independent training, validation, and testing sets using an 85-5-10 percentage split by 
participant. This separation was performed at the participant (not image) level. This means that all images from 
a participant were included in the same partition (training, validation, or testing). This ensured that testing set 
Figure 1. Example input ONH image (top left) and images resulting from data augmentation. Each input image 
was augmented by horizontal mirroring to mimic alternative OD/OS orientation and random cropping to 
produce translations of the image.
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contained only images of novel eyes that had not been encountered by the model during training. For training, a 
total of 50,000 iterations with batch size of 25 (~10 epochs) were performed. Based on validation set performance, 
this was well past the point of convergence. After every 1,000 training iterations, the model was applied to the 
validation dataset to evaluate performance on unseen data. The model that achieved the highest performance on 
the validation dataset was selected for evaluation on the testing dataset. This process was repeated for each archi-
tecture (VGG16, Inception, ResNet), approach (native, pretrained), and cross validation fold. Table 2 summarizes 
training data and parameters.
Figure 2. (A) Schematics of the three CNN architectures evaluated here. These architectures included VGG16, 
Inception, and ResNet50. The Inception (B) and Residual (C) are used as building blocks for the Inception and 
ResNet50 architectures, respectively.
www.nature.com/scientificreports/
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All models were trained and evaluated on a machine running CentOS 6.6 using an NVIDIA Tesla K80 graph-
ics card. Model specification, training and optimization, and application were performed using Caffe tools37.
Model Evaluation. In each cross validation fold, evaluation was performed on the independent test dataset. 
Native and transfer learning versions of each architecture were evaluated using area under the receiver operating 
characteristic curve (ROC, AUC). Each model was applied to the augmented test images to generate a probability 
of GON ranging from 0.0 (predicted healthy) to 1.0 (predicted GON). The probabilities of each augmented image 
derived from the same original input image were averaged to generate a final image-level prediction.
Using the expert adjudicated grades as the ground truth, the mean and standard deviation of AUC values for 
each model was estimated across cross validation folds. AUCs were compared across models to identify statisti-
cally significant (p < 0.05) differences. Because the testing set contained multiple images of the same participant, 
considering the classification of each image independently may skew AUC estimates. To address this issue, a 
clustered AUC approach was used38. This approach using random resampling of the data to estimate AUC in 
the presence of multiple results from the same participant. Statistical analyses were performed using statistical 
packages in R39–41.
After identifying the best performing model, we evaluated its performance in separating healthy eyes from 
those with mild functional loss and those with moderate or severe loss. To perform this evaluation, GON images 
in the testing set were stratified by degree of functional loss into two groups: mild and moderate-to-severe. Images 
graded as GON by the reviewers were included in the mild group if they had a VF MD better than or equal to 
−6 dB and in the moderate-to-severe group with an MD worse than −6 dB. The mean and standard deviation 
of AUC of the best performing model in distinguishing between these three groups (healthy, mild functional 
loss, moderate-to-severe functional loss) was evaluated. The sensitivity of the model in identifying any, mild, and 
moderate-to-severe GON at varying levels of specificity was also computed to characterize model performance.
Visualizing Model Decisions. Deep learning models have often been referred to as “black boxes” because it 
is difficult to know the process by which they make predictions. To help open this black box and understand what 
features are most important for model to identify GON in fundus images two strategies were employed: (1) qual-
itative evaluation of exemplar healthy and GON images along with model predictions and (2) occlusion testing to 
identify image regions with the greatest impact on model predictions. The qualitative assessment was performed 
by an expert grader (C.B.) who reviewed testing set images for which the model produced high confidence true 
predictions (true positives and negatives), high confidence false predictions (false positives and negatives), and 
low confidence predictions (borderline predictions). Examples of each of these predictions were selected to help 
illustrate model decisions and images that led to model errors.
The decision-making process of the model was also illustrated through the use of occlusion testing. This tech-
nique overlays a blank window on an image before applying the model to quantify the impact of each region on 
the model prediction. By passing this window over the entire image, the areas with the greatest impact on model 
predictions can be identified42. To identify ONH regions that had the greatest impact on model predictions, 
occlusion testing was performed on the entire set of testing images. For this analysis, only the right-eye orienta-
tion of each image was used and the average occlusion testing maps for healthy and GON eyes were computed.
Results
Table 1 summarizes the clinical and demographic characteristics of the ONH photograph dataset for the healthy, 
mild, and moderate-to-severe glaucoma eyes considered in this work. The GON participants were older (64.0 vs. 
55.3 years), had worse MDs (−4.1 vs −0.76 dB), and had a greater proportion of individual of African descent 
(45.5% vs. 28.0%) than healthy participants.
Model Training and Selection. Model performance was evaluated on the validation datasets after every 
1,000 training iterations. Figure 3 illustrates model performance for the first 50,000 iterations. Regardless of 
architecture, transfer learning models had greater initial performance and tended to reach convergence in fewer 
iterations.
Model Evaluation. The native VGG16 model achieved an AUC of 0.83 (95% CI: 0.81–0.85) and the transfer 
learning VGG16 model achieved 0.89 (95% CI: 0.87–0.91) on the testing data. For the Inception model, native 
Parameter Value
Weight Initialization Native: Random initialization, Transfer learning: Pre-trained on ImageNet
Training set sample size/fold 2,006 participants, ~3,710 eyes, ~12,595 images
Validation set sample size/fold 97 participants, ~218 eyes, ~745 images
Testing set sample size/fold 226 participants, ~436 eyes, ~1,482 images
Input image size 224 × 224 pixels
Network output Softmax probability of GON
Number of training iterations 50,000 (~10 epochs)
Learning rate 0.005 (iters. 0–100,00)
Table 2. Summary of the parameters used in training the deep learning models.
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AUC was 0.83 (95% CI: 0.81–0.85) and transfer learning AUC was 0.90 (95% CI: 0.88–0.92). Finally, native 
ResNet50 AUC was 0.89 (95% CI: 0.87–0.91) and transfer learning ResNet50 achieved the highest overall AUC 
of 0.91 (95% CI: 0.90–0.93). This transfer learning ResNet model AUC was higher than all other models, signif-
icantly (p < 0.05) so in all cases except for the transfer learning inception model. See Fig. 4 for ROC curves and 
Table 3 for a summary of these results. In all cases, the transfer learning models outperformed their native coun-
terparts on the testing dataset.
The best performing model (transfer learning ResNet50) was also evaluated based on its ability to distinguish 
healthy eyes from GON eyes with mild functional loss and GON eyes with moderate-to-severe functional loss. 
In identifying GON eyes with mild functional loss, the model achieved an AUC of 0.89 (95% CI: 0.88–0.90). In 
the case of GON eyes with moderate-to-severe loss, the model had an AUC of 0.97 (95% CI: 0.96–0.98). The 
transfer learning inception model achieved a sensitivity and specificity of 0.84 (95% CI: 0.83–0.85) and 0.83 (95% 
CI: 0.81–0.84) in identifying any GON, 0.82 (95% CI: 0.80–0.84) and 0.82 (95% CI: 0.80–0.83) in identifying 
mild GON, and 0.92 (95% CI: 0.89–0.94) and 0.93 (95% CI: 0.92–0.95) in identifying moderate-to-severe GON. 
Tables 4 and 5 summarize the full AUC, sensitivity, and specificity of the transfer learning Inception model.
Visualizing Model Decisions. Figure 5 provides case examples of model predictions and expert-based 
truth. A sampling of correct, incorrect, and borderline examples is shown along with the model GON predictions 
and truth. Among the correct GON predictions, hallmarks of glaucoma are visible (localized and diffuse rim 
thinning) and absent in the correctly identified healthy examples. The borderline cases suffer from more image 
quality issues (blurring, poor contrast) than the other examples. In the incorrect cases, some healthy examples 
predicted as GON (false positives) exhibited some characteristics typically associated with glaucoma such large 
vertical cup-to-disc ratios on the order of 0.8.
Figure 3. Model performance on the validation dataset by iteration for the first 50,000 training iterations for 
the VGG16 (top), Inception (middle), and ResNet50 (bottom) architectures.
www.nature.com/scientificreports/
7SCIENtIfIC REPORTs |         (2018) 8:16685  | DOI:10.1038/s41598-018-35044-9
Figure 6 shows the results of occlusion testing to identify ONH areas that had the greatest impact on model 
decisions. Average occlusion testing maps are shown for each group to illustrate regions most important to iden-
tifying healthy and GON images. For both healthy and GON eyes, the neuroretinal rim areas were identified as 
most important and the periphery contributed comparatively little to model decisions. Specifically, a region of the 
inferior rim was identified as the most important in the average occlusion maps. In GON eyes (and healthy eyes, 
to a lesser extent), a secondary region along the superior rim and arcuate area was also identified as important.
Figure 4. ROC curves in predicting glaucomatous optic neuropathy (GON) for each deep learning architecture 
initialized using transfer learning.
Model AUC (95% CI) P-value
VGG16
   Native 0.83 (0.81–0.85) <0.001*
   Transfer Learning 0.89 (0.87–0.91) 0.045*
Inception
   Native 0.83 (0.81–0.85) <0.001*
   Transfer Learning 0.90 (0.88–0.92) 0.11*
ResNet50
   Native 0.89 (0.87–0.91) 0.01*
   Transfer Learning 0.91 (0.90–0.93) —
Table 3. GON detection accuracy of deep learning models on test dataset. *AUC significantly (p < 0.05) lower 
than the transfer learning ResNet50 model.
Metric
GON Level
Any Mild Moderate-to-Severe
AUC 0.91 (0.90–0.91) 0.89 (0.88–0.90) 0.97 (0.96–0.98)
Sensitivity 0.84 (0.83–0.85) 0.82 (0.80–0.84) 0.92 (0.89–0.94)
Specificity 0.83 (0.81–0.84) 0.82 (0.80–0.83) 0.93 (0.92–0.95)
Table 4. Accuracy of the best performing model (transfer learning ResNet50) in identifying any, mild, and 
moderate-to-severe glaucomatous optic neuropathy shown along with 95% CI.
Specificity
Sensitivity by Disease Severity
Any Mild Moderate-to-Severe
0.80 0.85 (0.83–0.87) 0.83 (0.80–0.85) 0.96 (0.94–0.98)
0.85 0.80 (0.78–0.83) 0.77 (0.74–0.80) 0.95 (0.92–0.98)
0.90 0.74 (0.71–0.76) 0.69 (0.65–0.72) 0.93 (0.89–0.96)
0.95 0.62 (0.59–0.65) 0.55 (0.51–0.59) 0.88 (0.85–0.91)
Table 5. Sensitivity of the best performing model (transfer learning ResNet50) in identifying any, mild, and, 
moderate-to-severe GON at varying levels of specificity.
www.nature.com/scientificreports/
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Discussion
Our results suggest that deep learning methodologies have high diagnostic accuracy for identifying fundus pho-
tographs with glaucomatous damage to the ONH in a racially and ethnically diverse population. The best per-
forming model was the transfer learning ResNet architecture and achieved an AUC of 0.91 in identifying GON 
from fundus photographs, outperforming previously published accuracies of automated systems for identifying 
GON in fundus images. These included systems based on traditional image processing and machine learning 
classifiers as well as those that used deep learning approaches (AUCs in range of 0.80–0.89)43–45. The model had 
even higher performance (AUC of 0.97, sensitivity of 90% at 93% specificity) in identifying GON in eyes with 
moderate-to-severe functional damage.
The accuracy of this approach may help make automated screening programs for glaucoma based on ONH 
photographs a viable option to improve disease detection in addition to providing decision-making support for 
eye care providers. Previous work has shown that limited sensitivity and specificity of tests reduce the feasibility of 
screening programs given low overall disease prevalence8,46,47. The model described here achieved a sensitivity of 
0.92 and specificity of 0.93 in identifying moderate-to-severe GON. This suggests that it may be able to accurately 
Figure 5. Predictions of the best performing model compared to expert truth. Examples of correct, incorrect, 
and borderline predictions are shown along with the expert truth and model glaucomatous optic neuropathy 
(GON) prediction probabilities (0 = healthy, 1 = GON).
www.nature.com/scientificreports/
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identify GON in specific screening situations while reducing the burden of false positives compared to other 
glaucoma-related measurements. Automated (rather than human) review of fundus photographs would also help 
reduce costs and aid in the implementation of large-scale screening programs by providing quick, objective and 
consistent image assessment. This deep learning model for glaucoma detection using ONH photographs could 
also be combined with deep learning-based assessment of fundus photography for referable diabetic retinopathy 
that has recently been approved by the FDA for use in primary care clinics.
Deep learning based review of fundus images could also be useful in glaucoma management as part of clin-
ical decision support systems through incorporation into fundus cameras, electronic medical records, or PACS 
systems. The quantitative GON probabilities provided by these models serve as a confidence score regarding the 
GON prediction – a borderline score near 0.5 may suggest additional scrutiny compared to a score of 0.0 or 1.0. 
Application of these models can also provide guidance to human reviewers about what specific image regions 
contributed to the model prediction (e.g. through occlusion testing). Clinicians can incorporate model predic-
tions and guidance along with all other patient-specific data for patient management decisions.
To help understand and visualize model decisions, a sample of the correct, incorrect, and borderline testing 
set examples were reviewed by an expert grader. Based on this additional review, the model does seem to identify 
glaucoma-related ONH features (e.g. rim thinning). However, image quality issues such as blurring or low con-
trast can cause model errors and low confidence (~0.50) predictions. For additional insight into model decisions, 
an occlusion testing procedure was performed. This technique identified areas of input images that had the great-
est impact on model output. To identify the regions that were most important across the entire dataset, average 
occlusion maps were computed for healthy and GON images (Fig. 6). These results show that, for this dataset, the 
model identified inferior and superior regions of the neuroretinal rim as the most important part of the posterior 
ocular fundus for distinguishing between GON and healthy eyes. These regions correspond to a longstanding 
rule-of-thumb in ONH evaluation that glaucoma damage often occurs first in the inferior region followed by the 
superior regions48. Based on occlusion testing, part of the model determination may be based on early changes or 
thinning of the thickest rim regions (inferior and superior). These hot spots both conform with areas of the disc 
and adjacent retina previously found to distinguish between GON and healthy eyes. This suggests that (in part) 
our model evaluates fundus photographs in a way similar to clinicians.
Li et al. recently published their results in training a deep learning model (using the Inception architecture) 
for identifying GON in fundus images49. Their deep learning model achieved an AUC of 0.986 in distinguish-
ing healthy from GON eyes, similar to our AUC of 0.97 for moderate to severe glaucoma. Several differences 
between the datasets may help account for this difference. First, the dataset used in Li et al. (LabelMe, http://
www.labelme.org) contained a greater number of images (~39,000 vs. ~7,000 fundus images) and eyes (~39,000 
vs. ~4,000 eyes). Because of the high data requirements of deep learning models, the addition of thousands of 
fundus images would help improve performance substantially. Moreover, while the decision healthy vs. GON was 
left up to grader judgement in this work, Li et al. used stricter criteria for defining GON. Images were required to 
display at least one of the following to be labeled as GON: cup-to-disc ≥0.70, localized notching with rim width 
Figure 6. Mean occlusion testing maps showing most significant regions for distinguishing healthy and 
glaucomatous optic neuropathy (GON) images. In these images, bright pink regions indicate a large impact 
on model predictions while dark blue regions indicate a very limited impact on predictions. The maps were 
generated by averaging occlusion testing maps of the healthy and GON testing images in right eye orientation. 
The heat maps (bottom) are shown overlaid on a representative healthy and GON eye (top).
www.nature.com/scientificreports/
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≤0.1 disc diameter, visible nerve fiber layer defect, or disc hemorrhage. The required presence of one or more of 
these features likely meant that the GON images in Li et al. represented more advanced disease than many GON 
images in the current study. Comparing our performance in identifying moderate-to-severe GON, the models 
achieved similar performance (0.97 vs. 0.986 AUC). In addition, their dataset was collected from a more racially 
homogenous population. The LabelMe dataset used in Li et al. was collected from an almost exclusively Chinese 
population, while the data considered here was collected from a more geographically and racially diverse popu-
lation of individual of European descent (~60%) and African descent (~35%) from California, Alabama and New 
York. There are important differences in ONH appearance and structure across different populations including 
differences in disc size, cup and rim size, and cup-to-disc ratio50. The heterogeneity of our dataset meant that our 
model needed to learn GON-related features in different racial groups. Stratifying the test set by race, suggests 
that the deep learning model provides similar accuracy in individuals of European descent and individuals of 
African descent with AUCs of 0.91 (0.89–0.92) and 0.90 (0.89–0.92 (p = 0.83), respectively. The diverse popula-
tion of our training, validation, and testing datasets may have resulted in a more generalizable model. However, 
these results are limited in that only two groups (European and African descent) comprised ~95% of the partici-
pants. Evaluation and training on independent datasets with greater representation of additional populations will 
help quantify and improve model generalizability.
Comparing the results of different deep learning architectures (VGG16 vs. Inception vs. ResNet50) and strat-
egies (native vs. transfer learning) may help provide guidance for future development of models to identify GON. 
The performance of the ResNet50 architecture was significantly better than that of the VGG16 and Inception 
architectures. These results are consistent with the relative performance of these architectures on general image 
classification tasks. ResNet incorporates residual layers to help aid the model achieve convergence during training 
of very deep networks such as these51. These residual layers seemed to aid the model in learning GON-related 
image features and resulted in significantly higher performance.
For all deep learning architectures, transfer learning increased performance in detecting GON and decreased 
the training time needed for model convergence. A possible reason that transfer learning helps the model learn 
faster with less data is that it mimics the way our visual system develops. The visual system develops circuits to 
identify simple features such (e.g. edges and orientation), combines these features to process more complex scenes 
(e.g. extracting and identifying objects), and associates this complex set of features with other knowledge regard-
ing the scene. By the time a clinician learns to interpret medical images, they already have vast experience in 
interpreting a wide variety of visual scenes. Initializing models via transfer learning is an important approach that 
should be considered whenever training a CNN to perform a new task, especially when limited data is a concern.
There are some limitations to this study. The ground truth used here was derived from the generally accepted 
gold standard of subjective assessment of stereoscopic fundus photography by at least 2 graders certified by the 
UCSD Optic Disc Reading Center with adjudication by a third experienced grader in cases of disagreement. 
Because the images were collected and reviewed over the course of ~15 years, the ground truth was not generated 
by a single pair of graders and a single adjudicator. This means that model classifications cannot be compared to 
2 specific graders to determine agreement. Rather, our results were compared to the ground truth based on the 
final grade. For our dataset, two graders agreed in the assessment of an image in approximately 77% of cases and 
adjudication was required in approximately 23% of cases. This is comparable to previously published levels of 
agreement between graders and in ground truth data used in training automated systems52,53.
For our analysis, stereo pairs were separated and treated as separate, non-stereo images during classification. 
In many circumstances, however, stereoscopic photographs are not available for GON evaluation and are gener-
ally not used in screening situations. Thus, while including stereoscopic information may eventually enhance per-
formance, separating stereo pairs for our analysis mimics situations in which stereo information is not available 
and increases the generalizability of our results to non-mydriatic cameras used in population-based and primary 
care based screening programs6. A limitation of the current results, however, is that the effect of specific camera 
type/model on performance could not be quantified. For this retrospective dataset, the original film-based cam-
era model and settings were not available. The digitization of the film photographs, however, was standardized 
and consistent. Future work should include training and evaluation of models on images collected using multiple, 
known cameras. This would aid clinicians in selecting deep learning models most appropriate for their imaging 
instruments.
Additionally, the ONH region was extracted from the images and used as input to the model. This was done to 
ensure that the model was exposed to a fairly consistent, ONH-centered view. During expert review for this study, 
GON grades were assigned using the information provided by stereo photos that included areas peripheral to the 
disc with visual information on the retinal nerve fiber layer available for some photographs. For example, post-hoc 
assessment of full stereo photographs from healthy eyes that were incorrectly predicted as GON revealed healthy 
superior and inferior arcuate RNFL bundles outside the region of the cropped ONH image (Fig. 5). Considering 
only the cropped ONH region, the large cup-to-disc ratios and possible rim thinning likely led to the incor-
rect model prediction. In other cases, however, healthy eyes with large discs or cups were correctly classified 
by the model even without the additional context provided by the full stereo photographs. Future work should 
investigate the effect of the ONH region size, resolution, and incorporation of stereo information on model per-
formance. Incorporating more of the periphery and stereo information may help to improve identification of 
glaucomatous damage54.
In addition, the dataset under consideration included multiple images captured over several years from most 
participants. This longitudinal component contains important information and clinicians regularly evaluate fun-
dus photographs in comparison to a baseline photograph to determine the extent (or rate) of glaucomatous dam-
age. For the current study, the longitudinal aspect of the data was not considered and the entire dataset was used 
train models that considered each image individually. In addition to cross sectional data, there is potential for 
the analysis of longitudinal data to detect progression using deep learning approaches. Although standard deep 
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learning CNN architectures are not designed to work on longitudinal data, there are recurrent CNN variants that 
consider a sequence of images55. These recurrent networks include a temporal component so that information 
from multiple images captured sequentially can be combined to produce a single prediction. Using the dataset 
described here, future work could include training models that use longitudinal images to increase the confidence 
of GON predictions, estimate the incidence of glaucoma progression, or predict the extent and type of damage at 
a future time point.
In summary, the best performing deep learning model had expert-level accuracy (AUC = 0.91) in identifying 
any GON and even higher accuracy (AUC = 0.97) in identifying GON with moderate-to-severe functional dam-
age. Given the increasing burden of glaucoma on the healthcare system as our population ages and the prolifer-
ation of ophthalmic image devices, automated image analysis methods will serve an important role in decision 
support systems for patient management and in population- and primary care-based screening approaches for 
glaucoma detection. The results presented here suggest that deep learning based review of ONH images is a viable 
option to help fill this need.
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